Zhang Financial’s Biolase, Inc. BIOL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-13,770
| Closed | -$15.5K | – | 276 |
|
|
2023
Q4 | $15.5K | Buy |
13,770
+1,692
| +14% | +$1.9K | ﹤0.01% | 254 |
|
|
2023
Q3 | $22.5K | Buy |
12,078
+10,429
| +632% | +$19.4K | ﹤0.01% | 232 |
|
|
2023
Q2 | $11.7K | Buy |
1,649
+1,440
| +689% | +$10.2K | ﹤0.01% | 246 |
|
|
2023
Q1 | $5.88K | Buy |
+209
| New | +$5.88K | ﹤0.01% | 228 |
|
|
2022
Q2 | – | Sell |
-27
| Closed | -$24K | – | 236 |
|
|
2022
Q1 | $24K | Buy |
27
+4
| +17% | +$3.56K | ﹤0.01% | 217 |
|
|
2021
Q4 | $22K | Buy |
23
+18
| +360% | +$17.2K | ﹤0.01% | 207 |
|
|
2021
Q3 | $8K | Buy |
+5
| New | +$8K | ﹤0.01% | 165 |
|